'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis.
نویسندگان
چکیده
Ann Rheum Dis April 2010 Vol 69 No 4 629 1Department of Cardiology, Oslo University Hospital, Aker and Ullevål, Oslo, Norway 2Faculty of Medicine, University of Oslo, Oslo, Norway 3Department of Endocrinology, Oslo University Hospital, Oslo, Norway 4Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway Correspondence to Professor Dan Atar, Department of Cardiology, Division of Medicine B, Oslo University Hospital, Kirkeveien 166, Oslo 0407, Norway; [email protected] ‘Treat to target’: moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis Dan Atar,1,2 Kåre Inge Birkeland,2,3 Till Uhlig4
منابع مشابه
Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care.
"Treat-to-target" of rheumatoid arthritis (RA) is similar in many respects to hypertension and diabetes. All three diseases involve a dysregulation of normal physiologic functions, which results in long-term organ damage if not treated. "Treat-to-target" strategies, based on values of specific quantitative measures, lead to improved outcomes, including longer survival. However, RA differs from ...
متن کاملA Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient
Methotrexate is an anti-rheumatic agent used as a first-line tretment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Methotrexate, but are very uncommon. We report here the first Moroccan case of RA patient on low dose MTX, who developed AML. We also reviewed all similar cases.
متن کاملProteases as drug targets.
The effective management of AIDS with HIV protease inhibitors, or the use of angiotensin-converting enzyme inhibitors to treat hypertension, indicates that proteases do make good drug targets. On the other hand, matrix metalloproteinase (MMP) inhibitors from several companies have failed in both cancer and rheumatoid arthritis clinical trials. Mindful of the MMP inhibitor experience, this chapt...
متن کاملTreating rheumatoid arthritis to target: recommendations of an international task force
BACKGROUND Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid arthritis (RA). OBJECTIVE /st> To develop recommendations for achieving optimal therapeutic outcomes in RA. METHODS A task force of rheumatologists and a patient developed a set of recommendations on the basis of ...
متن کاملManagement of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
BACKGROUND Treat-to-target therapy approaches are established for chronic diseases such as diabetes, hypertension, and more recently rheumatoid arthritis, resulting in improved patient outcomes. These approaches do not use patient reported outcomes (PRO) as targets of therapy. Chronic spontaneous urticaria (CSU), also called chronic idiopathic urticaria (CIU), is defined as recurrent urticaria ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of the rheumatic diseases
دوره 69 4 شماره
صفحات -
تاریخ انتشار 2010